drugset / Trial / NCT07012863

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

NCT07012863 ↗

Phase 4 Not yet recruiting 650 enrolled Vastra Gotaland Region
RandomizedParallel-groupDouble-blindTreatment

Summary

The overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock. Researchers will compare dry plasma to standard care to see if dry plasma improves survival compared to crystalloid fluid in prehospital patients with heavy bleeding.

Timeline

Start
2026-01-01
Primary completion
2027-06-30
Completion
2027-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dry plasma Unknown — Intravenous